Regulation of the ankyrin-B-based targeting pathway following myocardial infarction - Wikidata - awgldk - TriplyDB

Regulation of the ankyrin-B-based targeting pathway following myocardial infarction

Regulation of the ankyrin-B-based targeting pathway following myocardial infarction

http://www.wikidata.org/entity/Q37096967

about

EH domain proteins regulate cardiac membrane protein targeting Ankyrin-B regulates Kir6.2 membrane expression and function in heart Interactions between ankyrin-G, Plakophilin-2, and Connexin43 at the cardiac intercalated disc Novel Variant in the ANK2 Membrane-Binding Domain Is Associated With Ankyrin-B Syndrome and Structural Heart Disease in a First Nations Population With a High Rate of Long QT Syndrome.Oxidized calmodulin kinase II regulates conduction following myocardial infarction: a computational analysis.Defining a new paradigm for human arrhythmia syndromes: phenotypic manifestations of gene mutations in ion channel- and transporter-associated proteins.Defining new insight into atypical arrhythmia: a computational model of ankyrin-B syndrome CaMKII inhibition rescues proarrhythmic phenotypes in the model of human ankyrin-B syndrome.Atrial fibrillation and sinus node dysfunction in human ankyrin-B syndrome: a computational analysis.Cardiac ankyrins in health and disease Structural basis of diverse membrane target recognitions by ankyrins.Coordinating electrical activity of the heart: ankyrin polypeptides in human cardiac disease.Defects in cytoskeletal signaling pathways, arrhythmia, and sudden cardiac death.Molecular mechanisms underlying cardiac protein phosphatase 2A regulation in heart.Ca2+/calmodulin-dependent protein kinase II-based regulation of voltage-gated Na+ channel in cardiac disease.β(IV)-Spectrin regulates TREK-1 membrane targeting in the heart.Protein phosphatase 2A affects myofilament contractility in non-failing but not in failing human myocardium Murine Electrophysiological Models of Cardiac Arrhythmogenesis.A Novel Mechanism for Human Cardiac Ankyrin-B Syndrome due to Reciprocal Chromosomal Translocation.Cardiac spectrins: alternative splicing encodes functional diversity.Ankyrins and Spectrins in Cardiovascular Biology and Disease.Spectrin-based pathways underlying electrical and mechanical dysfunction in cardiac disease.The evolving role of ankyrin-B in cardiovascular disease.Novel Mechanistic Roles for Ankyrin-G in Cardiac Remodeling and Heart Failure

P2860

Q24314283-07808B14-2F93-4DAE-B209-366C92DB9A8B Q24338086-3AAAAFDE-9BFA-4020-921E-CCAFA12A2022 Q28238713-046F98E0-D74D-4BE2-8142-F3FD5F7884D7 Q33168257-D335C573-4C44-489F-879F-165528C0C3B0 Q33517622-3A014C65-D0A1-452F-A8A2-E0693D148925 Q34095165-30E6CC15-1CAA-4634-A7AA-FEFCF43C4EB9 Q34132568-CA60A786-7307-42CC-BAF4-0ABBF3185B12 Q34305581-7F5050A9-C2D1-473E-B909-7A7A61068056 Q34329504-0837D37B-8265-4204-872D-8346628D27C3 Q34977809-88E9C546-BEDD-4E6E-BEBD-87EC5DBFFD1D Q35173196-DA8E9C05-E6FE-46AA-8767-90E57509C01D Q35195291-A71F05F0-5E94-471C-AD9F-1F43B3692D52 Q35931890-CA9B9D7B-B903-483E-8A50-22EF38621FD1 Q36526222-1D6D8747-8D81-42ED-A94B-BC36E0A2786B Q37262717-0818A2FD-5653-4D45-9E82-007A46F5DF34 Q37644762-B97F8448-23CD-4A29-9BED-A6133E8DE962 Q38888204-2F2EC96D-BB53-41A5-AFDF-15E48C467700 Q39038606-0A0727F9-CF38-45D5-B9A2-8B1625E19021 Q39132271-08BA369A-99D4-41BC-BD3B-2F3C009C0E87 Q42788786-DFEEC4E8-FC66-430C-A166-22134A0845D1 Q44387346-BC4E35E1-423F-40B9-94B5-CB33CC830DDD Q47234942-BCC3ACAD-F625-4038-90E7-037BBA923EF0 Q48002945-01F155C3-B6F2-45F6-906D-BDE0F83029C9 Q59129605-BB35B734-7C72-48AE-A5E1-18C0AEC4BCA4

P2860

Regulation of the ankyrin-B-based targeting pathway following myocardial infarction

http://www.wikidata.org/entity/Q37096967

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 14 December 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Regulation of the ankyrin-B-based targeting pathway following myocardial infarction

@en

Regulation of the ankyrin-B-based targeting pathway following myocardial infarction.

@nl

type

label

Regulation of the ankyrin-B-based targeting pathway following myocardial infarction

@en

Regulation of the ankyrin-B-based targeting pathway following myocardial infarction.

@nl

prefLabel

Regulation of the ankyrin-B-based targeting pathway following myocardial infarction

@en

Regulation of the ankyrin-B-based targeting pathway following myocardial infarction.

@nl

P1433

Q37096967-C81A0DEC-897B-451A-9B00-C252756B89AC

P1476

Q37096967-DD5F4E8C-874F-424A-892E-89839A397752

P2093

Q37096967-3548615F-B7E4-45A0-86DC-AA996300927B

Q37096967-6A69F16F-FCCA-4B06-984F-F7DCC6E52802

Q37096967-AF67029E-A853-4E60-8A32-1BAF3D0DF078

Q37096967-B5D75FAA-787F-45BE-9497-EE6A8DBCE409

Q37096967-D236D2FE-CA1C-42C6-B4DB-953DBD3577C9

Q37096967-ECBD21ED-4F32-4A29-B477-6984D3140D47

P2860

Q37096967-0AF225A6-CC68-4091-8A4E-FA63ADEA1374

Q37096967-1123B677-F3F3-4712-9DA6-34A76DC816DB

Q37096967-2ACA6AFB-5FCF-4434-A24D-9EA6A1D1FE14

Q37096967-3ECC0EDE-6436-4B5C-A62B-9C46338F4E8F

Q37096967-48C38FDC-53CD-4CE2-AE94-9DFD4BAC7D6A

Q37096967-48CEFD89-2F68-4B96-BB04-626EAB4B7E53

Q37096967-4D00C555-404D-4945-A795-862B9FF35F1A

Q37096967-653A409A-6C0F-4E73-BA2D-18E0BADE5265

Q37096967-65D315FC-71E7-42D3-AF26-7F831A3D0BC8

Q37096967-66DDF474-2550-46C4-A15A-8018E7CBAFD2

P304

Q37096967-D6034E1B-E32B-45F8-A13F-8E740F31CD8B

P31

Q37096967-BF55AABC-F8C4-49E4-B3B4-0970EEC3E0D0

P356

Q37096967-A72BEA6D-1472-4233-9D60-2418902B5E3C

P433

Q37096967-254B596E-8160-4DE6-818B-BE55B6949E61

P478

Q37096967-68C3A17B-89DE-4136-B3B3-936AD52478B1

P577

Q37096967-9E3FFAFF-C558-449D-8D48-B13219FF5830

P5875

Q37096967-FE214B19-4454-4E87-A4B2-D78628E878D9

P698

Q37096967-E8F29CF2-C014-4F8D-8BF6-92964E7FFA76

P921

Q37096967-97CD1E7C-F7E7-4507-B0C5-66187C33E9DF

P932

Q37096967-E662B8F4-8B0D-4E70-83BD-DDE4E05802C5

P356

P1433

Cardiovascular Research

P1476

Regulation of the ankyrin-B-based targeting pathway following myocardial infarction

@en

P2093

Jedidiah S Snyder

http://www.w3.org/2001/XMLSchema#string

Patrick J Wright

http://www.w3.org/2001/XMLSchema#string

Penelope A Boyden

http://www.w3.org/2001/XMLSchema#string

Peter J Mohler

http://www.w3.org/2001/XMLSchema#string

Thomas J Hund

http://www.w3.org/2001/XMLSchema#string

Wen Dun

http://www.w3.org/2001/XMLSchema#string

P2860

Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

Defining the cellular phenotype of "ankyrin-B syndrome" variants: human ANK2 variants associated with clinical phenotypes display a spectrum of activities in cardiomyocytes

Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death

Ankyrin-B coordinates the Na/K ATPase, Na/Ca exchanger, and InsP3 receptor in a cardiac T-tubule/SR microdomain.

Ankyrin-B targets beta2-spectrin to an intracellular compartment in neonatal cardiomyocytes

Obscurin targets ankyrin-B and protein phosphatase 2A to the cardiac M-line

Dysfunction in ankyrin-B-dependent ion channel and transporter targeting causes human sinus node disease

Nav1.5 E1053K mutation causing Brugada syndrome blocks binding to ankyrin-G and expression of Nav1.5 on the surface of cardiomyocytes

[Beta]IV-spectrin regulates sodium channel clustering through ankyrin-G at axon initial segments and nodes of Ranvier

Increasing the ratio of PP2A core enzyme to holoenzyme inhibits Tat-stimulated HIV-1 transcription and virus production

P304

742-749

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CVR/CVN348

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

81

http://www.w3.org/2001/XMLSchema#string

P577

2008-12-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23655721

http://www.w3.org/2001/XMLSchema#string

P698

19074823

http://www.w3.org/2001/XMLSchema#string

P921

P932

2642599

http://www.w3.org/2001/XMLSchema#string